BillionToOne CEO and spouse sell 19,334 shares
The reported sales were made under separate Rule 10b5-1 plans adopted by Atay and his spouse on June 5 and June 7, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
BillionToOne, Inc. (BLLN) Chairman and CEO Oguzhan Atay exercised 16,667 options at $2.80 per share on October 12, 2026, acquiring 16,667 Class A shares. The options were fully vested and exercisable.
The transactions reported sales of 19,334 Class A shares, including five direct sale transactions and 2,667 shares sold by Atay’s spouse. The direct sale rows reported weighted-average prices from $91.5712 to $96.3924 per share; the spouse’s sale had a $97.6100 weighted-average price. Atay’s transactions were under a Rule 10b5-1 plan adopted June 5, 2026; his spouse’s sale was under a separate plan adopted June 7, 2026. The spouse-held position following the sale was reported as 151,835 shares.
Insights
Analyzing...
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (right to buy) F9 | 16,667 | $2.80 | $47K |
| Exercise | Class A Common Stock F1 | 16,667 | $2.80 | $47K |
| Sale | Class A Common Stock F1, F2 | 1,961 | $91.5712 | $180K |
| Sale | Class A Common Stock F1, F3 | 2,553 | $93.046 | $238K |
| Sale | Class A Common Stock F1, F4 | 6,763 | $93.647 | $633K |
| Sale | Class A Common Stock F1, F5 | 3,869 | $94.6133 | $366K |
| Sale | Class A Common Stock F1, F6 | 1,521 | $96.3924 | $147K |
| Sale | Class A Common Stock F7, F8 | 2,667 | $97.61 | $260K |
Footnotes (9)
- F1. The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2026.
- F2. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.250 to $92.170 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.2596 to $93.255 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F4. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.260 to $94.225 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F5. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.265 to $95.205 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F6. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.945 to $96.765 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F7. The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person's spouse on June 7, 2026.
- F8. Represents shares held by the Reporting Person's spouse.
- F9. The options are fully vested and exercisable.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
weighted average price financial
fully vested and exercisable financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many BLLN options did Oguzhan Atay exercise, and at what price?
What prices were reported for the BLLN sales?
AI-generated analysis. How Rhea-AI works. Not financial advice.